Outcomes From a Regional Synchronous Tele-Allergy Service

Waibel, Kirk H.; Bickel, Richard A.; Brown, Tyson C.

doi:10.1016/j.jaip.2018.10.026

Cited by 24 publications

(33 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nearly 97% agreed or strongly agreed that they were satisfied with their telemedicine encounter. These rates mirror similar work by Staicu et al 3 and Waibel et al 6 who found that 98% of patients were satisfied with a telemedicine evaluation. In addition, in our study, most patients thought that their telemedicine encounter was as satisfactory as an in-person encounter, whereas only 12.8% of patients disagreed with this sentiment.…”

supporting

confidence: 87%

“…However, previous data have indicated that patient care outcomes are comparable with telemedicine vs in-person visits 7,8 and that telemedicine can result in cost savings. 6 Comparing video visits with telephone and in-person visits would have also strengthened our study. Nevertheless, our data on telemedicine mirror the high level of patient satisfaction that has been previously reported.…”

mentioning

confidence: 85%

See 1 more Smart Citation

Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic

Mustafa

Yang

Mortezavi

et al. 2020

Annals of Allergy, Asthma & Immunology

View full text Add to dashboard Cite

supporting

confidence: 87%

mentioning

confidence: 85%

Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic

Mustafa

Yang

Mortezavi

et al. 2020

Annals of Allergy, Asthma & Immunology

View full text Add to dashboard Cite

“…Further, most patients in our cohort had chronic diseases and required at least one follow-up via telemedicine. Compared to other studies, the reasons for consultation via telemedicine markedly differed from the ones in our centre: one centre consisted of adverse drug reaction (66%), immunodeficiency (15%) and urticaria (5%), whereas the other centre consisted of allergic rhinitis (30%), asthma (24%) and food allergy (10%) [ 3 , 9 ]. Lastly, because there are very few centres that specialize in immunodeficiency care, our study showed that telemedicine allowed patients who lived in remote areas to be connected to the allergists/immunologists in urban centres and reduced the potential travel distance, similar to the reported travel distance in another study (718 km vs. 700 km, respectively) [ 9 , 10 ].…”

Section: Discussioncontrasting

confidence: 68%

“…Telemedicine use in CIA has been increasing in the US, particularly in adverse drug reactions and immunodeficiency, resulting in rapid turnaround time and decreased wait time [ 3 ]. It also has been associated with significant time and cost savings, as well as high patient satisfaction compared to in-person visits [ 9 ]. Despite the evidence to support telemedicine for CIA care, it had been underutilized in Canada before the pandemic.…”

Section: Discussionmentioning

confidence: 99%

Characterizing telemedicine use in clinical immunology and allergy in Canada before the COVID-19 pandemic

Lee

Song

Vadas

et al. 2021

Allergy Asthma Clin Immunol

View full text Add to dashboard Cite

Rationale There exists a geographic barrier to access CIA care for patients who live in rural communities; telemedicine may bridge this gap in care. Herein we characterized the use of telemedicine in CIA at a population-based level and single centre. Methods Before the COVID-19 pandemic, telemedicine care was provided via the Ontario Telemedicine Network (OTN) in Ontario, Canada. Descriptive data were collected from the OTN administrative database and from electronic medical records at a single academic centre during 2014 to 2019. The potential distance travelled and time saved by telemedicine visits were calculated using postal codes. Results A total of 1298 telemedicine visits was conducted over OTN, with an average of 216 visits per year. Only 11% of the allergists/immunologists used telemedicine to provide care before the COVID-19 pandemic. In the single centre that provided the majority of the telemedicine care, 66% patients were female and the overall mean age was 46. The most common diagnosis was immunodeficiency (40%), followed by asthma (13%) and urticaria (11%). Most patients required at least one follow-up via telemedicine. The average potential two-way distance travelled per visit was 718 km and the average potential time travelled in total was 6.6 h. Conclusion Telemedicine was not widely used by allergists/immunologists in Ontario, Canada before the COVID-19 pandemic. It could offer a unique opportunity to connect patients who live in remote communities and allergists/immunologists who practice in urban centres in Canada. Independent of the current pandemic, our study further highlights the need for more physicians to adopt and continue telemedicine use as well as for healthcare agencies to support its use as a strategic priority once the pandemic is over.

show abstract

“…They should be assigned and followed by proper advice on the basis of the differentiation of COVID‐19 symptoms from those due to the common cold, flu, allergic rhinitis, chronic rhinosinusitis and allergic asthma (Table 1). For this purpose, telemedicine is a useful instrument, but should be provided by a dedicated HCP 35,36 strictly following the general prerequisites of information technology (Section 5). The triage of urgent cases is highly important to determine those needing in‐person consultation and diagnostic procedures and those who can be managed effectively via telemedicine or scheduled for later dates.…”

Section: Care Of Allergic Patients: Preclinical Setting and Triage Ofmentioning

confidence: 99%

COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

Pfaar

Klimek

Jutel

et al. 2021

Allergy

155

View full text Add to dashboard Cite

Background The coronavirus disease 2019 (COVID‐19) has evolved into a pandemic infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS‐CoV‐2). Allergists and other healthcare providers (HCPs) in the field of allergies and associated airway diseases are on the front line, taking care of patients potentially infected with SARS‐CoV‐2. Hence, strategies and practices to minimize risks of infection for both HCPs and treated patients have to be developed and followed by allergy clinics. Method The scientific information on COVID‐19 was analysed by a literature search in MEDLINE, PubMed, the National and International Guidelines from the European Academy of Allergy and Clinical Immunology (EAACI), the Cochrane Library, and the internet. Results Based on the diagnostic and treatment standards developed by EAACI, on international information regarding COVID‐19, on guidelines of the World Health Organization (WHO) and other international organizations, and on previous experience, a panel of experts including clinicians, psychologists, IT experts, and basic scientists along with EAACI and the “Allergic Rhinitis and its Impact on Asthma (ARIA)” initiative have developed recommendations for the optimal management of allergy clinics during the current COVID‐19 pandemic. These recommendations are grouped into nine sections on different relevant aspects for the care of patients with allergies. Conclusions This international Position Paper provides recommendations on operational plans and procedures to maintain high standards in the daily clinical care of allergic patients while ensuring the necessary safety measures in the current COVID‐19 pandemic.

show abstract

Outcomes From a Regional Synchronous Tele-Allergy Service

Cited by 24 publications

References 10 publications

Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic

Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic

Characterizing telemedicine use in clinical immunology and allergy in Canada before the COVID-19 pandemic

COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

Contact Info

Product

Resources

About